| Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping S Kim, YT Lim, EG Soltesz, AM De Grand, J Lee, A Nakayama, JA Parker, ... Nature biotechnology 22 (1), 93-97, 2004 | 2702 | 2004 |
| Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion SZ Goldhaber, PC Come, RT Lee, E Braunwald, JA Parker, WD Haire, ... The Lancet 341 (8844), 507-511, 1993 | 1173 | 1993 |
| Comparison of interpolating methods for image resampling JA Parker, RV Kenyon, DE Troxel IEEE Transactions on medical imaging 2 (1), 31-39, 1983 | 1155 | 1983 |
| Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0 D Delbeke, RE Coleman, MJ Guiberteau, ML Brown, HD Royal, BA Siegel, ... Journal of nuclear Medicine 47 (5), 885-895, 2006 | 897 | 2006 |
| Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT) PA Cleary, W Dahms, D Goldstein, J Malone, WV Tamborlane J Pediatr 139 (1), 804-12, 2001 | 597 | 2001 |
| Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and … TWT for the Diabetes, ... JAMA: the journal of the American Medical Association 290 (16), 2159, 2003 | 523 | 2003 |
| Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism SZ Goldhaber, J Heit, G Sharma, JS Nagel, D Kim, JA Parker, D Drum, ... The Lancet 332 (8606), 293-298, 1988 | 519 | 1988 |
| Evaluation of a new bipyridine inotropic agent—milrinone—in patients with severe congestive heart failure DS Baim, AV McDowell, J Cherniles, ES Monrad, JA Parker, J Edelson, ... New England journal of medicine 309 (13), 748-756, 1983 | 406 | 1983 |
| Myocardial salvage after intracoronary thrombolysis with streptokinase in acute myocardial infarction: assessment by intracoronary thallium-201 JE Markis, M Malagold, JA Parker, KJ Silverman, WH Barry, AV Als, ... New England Journal of Medicine 305 (14), 777-782, 1981 | 357 | 1981 |
| Thrombolytic therapy for pulmonary embolism: frequency of intracranial hemorrhage and associated risk factors DS Kanter, KM Mikkola, SR Patel, JA Parker, SZ Goldhaber Chest 111 (5), 1241-1245, 1997 | 356 | 1997 |
| Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism LB Daniels, JA Parker, SR Patel, F Grodstein, SZ Goldhaber The American journal of cardiology 80 (2), 184-188, 1997 | 341 | 1997 |
| The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0 EB Silberstein, A Alavi, HR Balon, SEM Clarke, C Divgi, MJ Gelfand, ... Journal of Nuclear Medicine 53 (10), 1633-1651, 2012 | 335 | 2012 |
| Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation J Wykrzykowska, S Lehman, G Williams, JA Parker, MR Palmer, S Varkey, ... Journal of nuclear medicine 50 (4), 563-568, 2009 | 323 | 2009 |
| Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial SZ Goldhaber, CM Kessler, JA Heit, CG Elliott, WR Friedenberg, ... Journal of the American College of Cardiology 20 (1), 24-30, 1992 | 289 | 1992 |
| Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin™ radioimmunotherapy for low-grade, follicular, or transformed B … GA Wiseman, CA White, RB Sparks, WD Erwin, DA Podoloff, D Lamonica, ... Critical reviews in oncology/hematology 39 (1-2), 181-194, 2001 | 244 | 2001 |
| Hemodynamic and autonomic nervous system responses to mixed meal ingestion in healthy young and old subjects and dysautonomic patients with postprandial hypotension. LA Lipsitz, SM Ryan, JA Parker, R Freeman, JY Wei, AL Goldberger Circulation 87 (2), 391-400, 1993 | 239 | 1993 |
| Regional ejection fraction: a quantative radionuclide index of regional left ventricular performance. DE Maddox, J Wynne, R Uren, JA Parker, J Idoine, LC Siegel, JM Neill, ... Circulation 59 (5), 1001-1009, 1979 | 212 | 1979 |
| Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein M Ruel, RJ Laham, JA Parker, MJ Post, JA Ware, M Simons, FW Sellke The Journal of thoracic and cardiovascular surgery 124 (1), 28-34, 2002 | 206 | 2002 |
| Prognostic significance of right ventricular hypokinesis and perfusion lung scan defects in pulmonary embolism MW Wolfe, RT Lee, ML Feldstein, JA Parker, PC Come, SZ Goldhaber American heart journal 127 (5), 1371-1375, 1994 | 206 | 1994 |
| Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis KM Mikkola, SR Patel, JA Parker, F Grodstein, SZ Goldhaber American heart journal 134 (1), 69-72, 1997 | 194 | 1997 |
